Company: ZK
Filing Date: 2025-03-20
Form Type: 20-F
Source: 0001410578-25-000390
Chunk: 55

Company: ZEEKR Intelligent Technology Holding Ltd
Filing Date: 2025-03-20
Form: 20-F
Item: Item 3
Chunk 55
---
, internal controls and financial reporting responsibilities.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Even if we achieve the expected benefits, they may not be achieved within the anticipated time frame. Also, the synergies from our acquisition of Lynk & Co may be offset by costs incurred in the acquisition, losses of or disputes with key customers, suppliers, shareholders and employees of Lynk & Co Group, increases in other expenses, operating losses, liabilities or problems in the business unrelated to our collaboration. As a result, there can be no assurance that these synergies will be achieved.

31

From time to time we may evaluate and potentially consummate strategic investments or acquisitions, which could require significant management attention, disrupt our business and adversely affect our financial results.
We may evaluate and consider strategic investments, combinations, acquisitions or alliances to enhance our competitive position. These transactions could be material to our financial condition and results of operations if consummated. If we are able to identify an appropriate business opportunity, we may not be able to successfully consummate the transaction and, even if we do consummate such a transaction, we may be unable to obtain the benefits or avoid the difficulties and risks of such transaction, which may result in investment losses.
Strategic investments or acquisitions will involve risks commonly encountered in business relationships, including:

●   difficulties in assimilating and integrating the operations, personnel, systems, data, technologies, products and services of the acquired business;
--------------------------------------------------------------------------------------------------------------------------------------------------------

●   inability of the acquired technologies, products or businesses to achieve expected levels of revenue, profitability, productivity or other benefits including the failure to successfully further develop the acquired technology;
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

●   difficulties in retaining, training, motivating and integrating key personnel;
----------------------------------------------------------------------------------

●   diversion of management’s time and resources from our normal daily operations and potential disruptions to our ongoing businesses;
--------------------------------------------------------------------------------------------------------------------------------------

●   strain on our liquidity and capital resources;
--------------------------------------------------

●   difficulties in executing intended business plans and achieving synergies from such strategic investments or acquisitions;
------------------------------------------------------------------------------------------------------------------------------

●   difficulties in maintaining uniform standards, controls, procedures and policies within the overall organization;
---------------------------------------------------------------------------------------------------------------------

●   difficulties in retaining relationships with existing suppliers and other partners of the acquired business;
----------------------------------------------------------------------------------------------------------------

●   risks of entering markets in which we have limited or no prior experience;
------------------------------------------------------------------------------

●   regulatory risks, including remaining in good standing with existing regulatory bodies or receiving any necessary pre-closing or post-closing approvals, as well as being subject to new regulators with oversight over an acquired business;
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

●   assumption